Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2019-01-17 Regulatory Filings
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Hardman & Co Research: Allergy Therapeutics (AGY): Trading update: gaining market share
Regulatory Filings Classification · 99% confidence The document is a short announcement dated 17-Jan-2019 from 'Hardman & Co Research' regarding Allergy Therapeutics (AGY). It provides a brief trading update, mentions upcoming data (PQ Birch Phase III), and explicitly states, "Please click here for the full report: [link]". Since the document is very short (3879 chars) and serves primarily to announce the availability of a more detailed report (a research note), it fits the definition of a Report Publication Announcement (RPA) rather than the full research report itself (which might fall under IP or another category if it were the full content). This aligns with Rule #2 (The 'MENU VS MEAL' Rule).
2019-01-17 English
Trading Update & Notice of Results
Earnings Release Classification · 99% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'RNS Number : 1965N'. RNS stands for Regulatory News Service, which is the primary channel for regulatory announcements to the London Stock Exchange. The content provides a 'Trading Update & Notice of Results' for the six months ended 31 December 2018, scheduled to be announced on 6 March 2019. Since this is an announcement providing key financial highlights and updates ahead of the full interim report, it fits the description of an Earnings Release (ER) or a general regulatory announcement. However, given the explicit RNS tagging and the nature of providing a trading update ahead of a formal report, it is a specific type of regulatory filing. Since 'ER' is for the initial announcement of results, and this is a pre-announcement update, the most appropriate general category for a document explicitly marked as an RNS announcement that doesn't fit a more specific financial report type (like 10-K, IR, or DIV) is the general regulatory filing category, RNS. It is not the full Interim Report (IR) itself, but a notice about it and a trading update. H1 2019
2019-01-16 English
Group of companies' accounts made up to 2018-06-30
Regulatory Filings
2019-01-08 English
Holdings in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 9774I' and contains the standard format 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS, the specific content dictates the classification. The key elements are the notification of a holding crossing a threshold (5.33%) by BlackRock, Inc. on 28/11/2018. This aligns perfectly with the 'Major Shareholding Notification' category (MRQ).
2018-11-29 English
Result of AGM
AGM Information Classification · 99% confidence The document is an RNS announcement dated November 27, 2018, titled 'Result of Annual General Meeting'. It explicitly states that 'at its Annual General Meeting held this morning, all resolutions were duly passed.' This content directly relates to the outcomes of the Annual General Meeting. While it reports the results, the primary subject matter is the AGM itself, making 'AGM Information' (AGM-R) the most fitting category, as it covers materials shared during the AGM, which includes the results announcement. It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a Declaration of Voting Results (DVA), which usually contains the detailed breakdown of votes, whereas this is a summary announcement of the meeting's conclusion.
2018-11-27 English
AGM Trading Update
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number (5502I) and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The title is 'AGM Trading Update' and it explicitly states it is an update ahead of the Half Year Results. It contains operational updates, regulatory progress (FDA/MHRA), and mentions that the company 'will announce the results of the AGM voting later today.' Since this is a brief update released via RNS concerning ongoing business and regulatory progress, and it is not the full Annual Report (10-K), Interim Report (IR), or a specific announcement like a dividend (DIV) or management change (MANG), it fits best as a general Regulatory Filing (RNS). Although it mentions the AGM, it is not the voting results (DVA) or the AGM presentation itself (AGM-R), but rather a trading update released on the day of the AGM.
2018-11-27 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.